25 January 2022 - 25 January 2022
Gentili Soci e Amici ISPE, Sull’onda del successo della prima sessione vi ricordiamo la seconda sessione del 25 Gennaio 2022 del webinar del tradizionale GAMP Forum organizzato da ISPE e GAMP Italia. Questo secondo webinar, dopo le criticità della...
iSpeak Blog

There are many benefits to networking. In addition to strengthening business connections and meeting new people, it can help you discover new ideas and gain a fresh perspective on topics in the life sciences and pharmaceutical industries. It can help you advance your career and learn about new opportunities. Done properly, networking can introduce you to people that will become mentors and...

iSpeak Blog

ISPE’s Pharma 4.0™ initiative provides guidance, aligned with the regulatory requirements specific to the pharmaceutical industry, to accelerate Pharma 4.0™ transformations. Also known as the Smart Factory, the objective of Pharma 4.0 is to enable organizations involved in the product lifecycle to leverage the full potential of digitalization to provide faster innovations for the benefit of...

iSpeak Blog

One of the most significant changes to the pharmaceutical industry in the last decade has been the increased speed in developing new therapies. A striking example of this is the rapid rollout of the COVID-19 vaccines. What usually took 10-15 years was researched, developed, and put into production in less than a year after scientists successfully revealed the virus's genetic code in January of...

Off
The 2021 ISPE Pharma 4.0™ and Annex 1 Conference will bring together leading pharmaceutical and biopharmaceutical manufacturers, technology providers, academic scientists, and international regulators to network, share...
18 November 2021 - 18 November 2021
Next-Generation Virtual Experience Complimentary Learning Level: Intermediate Session Length: 4 hours In response to the recent COVID-19 pandemic, the urgency for rapid development, authorization/approval & supply continuity of a new mRNA platform...
iSpeak Blog

ICH Q10 outlines three objectives: achieve product realization, establish and maintain a state of control, and facilitate continual improvement. Embracing these objectives can be best achieved using the dual enablers, Knowledge Management (KM) and Quality Risk Management (QRM). The pharmaceutical industry has made significant progress in adopting QRM into systems and processes. However, the...

Subscribe to